Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

Share Price is delayed by 15 minutes
Get Live Data
25.75    0.00 (0.00%)
Bid:
25.50
Ask:
26.00
Spread: 0.50 (1.961%)
Market Cap: £129.66m
DUKE Live PriceLast checked at - London Stock Exchange

Intraday Duke Capital Share Chart

New Royalty Agreement

16 Dec 2021 07:00

RNS Number : 8149V
Duke Royalty Limited
16 December 2021
 

16 December 2021

 

Duke Royalty Limited

 

("Duke Royalty" or "Duke")

 

New Royalty Agreement with Specialist Social Care Business

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to announce that it has entered into a new £10.5 million royalty financing agreement (the "Financing") with Tristone Healthcare Limited ("Tristone"), further broadening its revenue base.

 

Tristone provides specialist residential and domiciliary care in two end markets: i) high acuity adults with severe mental, physical or learning disabilities; and ii) care leavers, aged 16-19, who are transitioning out of social care and into independent living.

 

Highlights:

 

· Initial cash yield of 13.5% per annum via monthly payments, which commence immediately.

· 30-year secured financing, with distributions to be adjusted annually to reflect Tristone's consolidated revenue growth, on typical Duke terms.

· Tristone's subsidiaries have a combined 40 year operating history, and offer a high degree of recurring revenue, with demonstrated organic growth.

· Formed in 2015, Tristone has acquired three specialist care businesses to date, and Duke expects to provide further financing over the next 18 months to fund Tristone's growing pipeline of bolt-on transactions.

· Duke's initial investment will refinance Tristone's existing capital structure.

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Duke Royalty is excited to be entering the UK care space. There is a growing need for high-quality operators in Tristone's end markets and the company has a strong reputation for delivering outstanding support. Our long-term funding helps Tristone grow capacity while removing refinancing risk, so the business can focus on allocating capital towards what matters - best-in-class care for vulnerable people.

 

"We are excited to back its CEO, Yannis, and the Tristone team as a royalty partner because they have a long-term vision, they exemplify social responsibility, and because partnering with Duke aligns with their goals."

 

Yannis Loucopoulos, CEO of Tristone, said:

 

"We were looking for a funding partner that shares our values and vision for building a group of care businesses with a long term, care-centric focus which prioritises delivering outstanding care and support.

 

"The long-term and non-controlling characteristics of this financing was compelling as it enables us to focus on what we do best without any refinancing risk and without having to compromise our values or approach. We look forward to working with the team to deliver our shared ambitions."

 

About Tristone

 

Tristone is committed to the acquisition and growth of social care companies which have proven business models. Tristone deeply understands the demands of social care and support and has extensive experience of investing in and building businesses of this nature, having supported a number of different care businesses since formation in 2015.

 

Tristone's management philosophy is to operate a simple and care-centric community of businesses that focus, first and foremost, on delivering outstanding care and support. Tristone's operating subsidiaries retain their identity and value base, and Tristone aims to help support existing management and staff teams to unlock further growth and value and ultimately positively impact more lives.

 

About the Financing

 

Duke has agreed to provide Tristone with a total investment line of up to £20 million. The remaining £9.5 million will primarily be drawn in the future for the acquisition of additional care homes and for general working capital purposes.

 

The terms of the Financing are broadly in line with Duke's typical investment criteria. The Financing is provided through a secured loan and Duke will be entitled to monthly distributions (the "Distribution") beginning in December 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in Tristone's total gross revenues for the 12 months to 31 March 2022, compared to the prior financial year. The first adjustment will occur from 30 June 2022. The annual adjustment in the Distribution will be subject to an agreed collar, in line with Duke's typical terms.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Tristone utilises an early buyback option which will trigger an early redemption payment to Duke.

 

Duke will also receive a 17.5% equity stake in the business as part of the transaction.

 

Duke Royalty Portfolio

 

A full list of Duke's current Royalty Partners are now included for reference on the Partners page of the Company's website: www.dukeroyalty.com/partners

 

This announcement contains inside information.

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Richard Bicknell / Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDKPBQKBDBDBD
Date   Source Headline
28th May 20267:00 amRNSNotice of Results & Investor Presentation
31st Mar 20267:00 amRNSTrading and Operational Update
19th Mar 20267:00 amRNSInterim Dividend and Dividend Declaration
26th Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
22nd Dec 20257:00 amRNSFollow-On Investment into Tristone Healthcare Ltd
18th Dec 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Dec 20257:00 amRNSInterim Financial Results
17th Oct 20257:00 amRNSFollow-On Investment into Step Investments Limited
1st Oct 20257:00 amRNSFollow-On Investment into Integrum Group Holdings
29th Sep 20257:00 amRNSTrading Update
18th Sep 20257:00 amRNSInterim Dividend and Dividend Declaration
4th Aug 202511:17 amRNSResult of Annual General Meeting
1st Aug 20258:08 amRNSDirector/PDMR Dealings
11th Jul 20257:00 amRNSAnnual Report & Notice of Annual General Meeting
25th Jun 20257:00 amRNSFinal Results for the year ended 31 March 2025
19th Jun 20257:00 amRNSInterim Dividend and Dividend Declaration
2nd Jun 20257:00 amRNSFollow-On Investment into Existing Capital Partner
27th May 20257:00 amRNSNotice of Results & Investor Presentation
2nd Apr 20257:00 amRNSFollow-On Investment into Existing Capital Partner
31st Mar 20257:00 amRNSTrading and Operational Update
20th Mar 20257:00 amRNSInterim Dividend and Dividend Declaration
19th Feb 20257:00 amRNSFollow-On Investment into BPVA (Ireland) Limited
30th Dec 20247:00 amRNSTrading and Operational Update
17th Dec 202412:50 pmRNSInterim Dividend and Dividend Declaration
16th Dec 20247:00 amRNSInterim Results for the six months ended 30 Sep 24
4th Dec 20249:40 amRNSDirector/PDMR Shareholding
3rd Dec 202411:34 amRNSResult of General Meeting and Issue of Equity
22nd Nov 20243:38 pmRNSResult of Retail Offer and Broker Option
15th Nov 20247:00 amRNSResult of Placing
14th Nov 20245:02 pmRNSRetail Offer to raise up to £3.0 million
14th Nov 20245:01 pmRNSIssue of Equity
30th Sep 20247:00 amRNSTrading and Operational Update
19th Sep 20247:00 amRNSInterim Dividend and Dividend Declaration
3rd Sep 20247:00 amRNSFollow-On Investment into United Glass Group
1st Aug 20243:16 pmRNSDirector/PDMR Dealings
1st Aug 202411:40 amRNSResult of Annual General Meeting
22nd Jul 20247:00 amRNSFollow-On Investment into Step Investments Limited
15th Jul 20247:00 amRNSAnnual Report & Notice of Annual General Meeting
27th Jun 20247:00 amRNSFinal Results for the year ended 31 March 2024
20th Jun 202411:50 amRNSInterim Dividend and Dividend Declaration
3rd Jun 20247:00 amRNSNotice of Results
17th May 202411:45 amEQSHardman & Co Q&A on Duke Capital (DUKE) | Generating investor returns by uniquely meeting customer needs
3rd May 20247:00 amRNSFollow-On Investment into Existing Capital Partner
29th Apr 20242:45 pmEQSHardman & Co Research Initiation of Coverage on Duke Capital (DUKE): Meeting customer needs, giving investors returns
3rd Apr 20247:00 amRNSFollow-On Investment into Existing Capital Partner
2nd Apr 20247:00 amRNSNew Capital Partner - Integrum Care
28th Mar 20247:00 amRNSTrading and Operational Update
21st Mar 20247:00 amRNSInterim Dividend and Dividend Declaration
7th Mar 20247:00 amRNSSuccessful Exit of Investment in Fabrikat

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.